Christopher A. Kroeger, CEO: MapLight Therapeutics MPLT Sell · Filed 05/18

Trade details

Type: Insider sale
Amount: $5,573.7
Shares · price: 198 sh · $28.15 a share
Held after: 1,394,094 sh
Stock: MapLight Therapeutics MPLT
Person: Christopher A. KroegerCEO
Trade date: 26/05/18
Filed: 26/05/18
Days to filing: 0 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

MapLight Therapeutics trades, last 26 weeks

What else happened in MapLight Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Christopher A. Kroeger's recent trades

Christopher A. KroegerCEO
Planned saleMapLight Therapeutics
Planned sale
MapLight Therapeutics
MPLT
$5.8M
152,230 sh
$5.8M
Filed 07/15
Traded 07/15
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$3.2M
118,037 sh
$3.2M
Filed 05/18
Traded 05/18
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$814.1K
29,624 sh
$814.1K
Filed 05/11
Traded 05/08
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$423.6K
14,880 sh
$423.6K
Filed 05/11
Traded 05/07
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$206.4K
6,871 sh
$206.4K
Filed 05/11
Traded 05/11